Categories
Cancer Care (474)
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (288)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (21)
Anti-inflammatory (13)
Antidepressants (9)
Ascorbic Acid (13)
autoantibodies (10)
autophagy (48)
Breast Cancer (30)
Cancer (69)
Cancer Stem Cells (11)
Chemotherapy (12)
Colon Cancer (11)
Corticosteroids (9)
COVID-19 (330)
COVID-19 Vaccines (8)
Curcumin (14)
Cytokines (13)
Depression (12)
Diabetes (14)
Famotidine (14)
Hydroxychloroquine (15)
Hyperbaric Oxygen Therapy (9)
Inflammation (15)
intermittent fasting (14)
ivermectin (53)
long COVID (21)
Macrophages (18)
Mast Cells (8)
Melatonin (23)
Mitochondria (14)
Myeloid Cells (10)
Pneumonia (9)
quercetin (15)
resveratrol (11)
SARS-CoV-2 (83)
Sepsis (22)
spermidine (11)
Spike Protein (12)
Thiamine (11)
Thrombosis (9)
Tinnitus (12)
Tumor (41)
Vitamin C (30)
Vitamin D (29)
Zinc (12)
SARS-CoV-2 infection is required for COVID-19, but many signs and symptoms of COVID-19 differ from common acute viral diseases. SARS-CoV-2 infection is necessary but not sufficient for development of clinical COVID-19 disease. Currently, there are no approved pre- or post-exposure prophylactic COVID-19 medical countermeasures. Clinical data suggest that famotidine may mitigate COVID-19 disease, but both mechanism of action and rationale for dose selection remain obscure.
Categories: MATH+
